Journal of Antimicrobial Chemotherapy (1995) 36, 225-230
© 1995 The British Society for Antimicrobial Chemotherapy
brief-report |
Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclines
Infectious Disease Research Section, Medical Research Division, American Cyanamid Company Pearl River, New York 10965, USA
Received 21 September 1994; returned 29 December 1994; accepted 14 February 1995
*Corresponding author. Phone: +1-(914)-73253463; Fax: +1-(914)-732 5536
The in-vitro activities of two glycylcyclines, DMG-MINO and DMG-DMDOT, and several comparative agents were determined against 263 enterococci, 102 methicillin-resistant Staphylococcus aureus and 55 Streptococcus pneumoniae recent clinical isolates. The glycylcyclines and teicoplanin were the most active agents against the enterococcal isolates. All methicillin-resistant S. aureus were susceptible to the glycylcyclines. Only DMG-DMDOT, ciprofloxacin, teicoplanin and vancomycin exhibited comparable activity against penicillin-susceptible, -intermediateand -resistant S. pneumoniae strains.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Hoffmann, W. DeMaio, R. A. Jordan, R. Talaat, D. Harper, J. Speth, and J. Scatina Metabolism, Excretion, and Pharmacokinetics of [14C]Tigecycline, a First-In-Class Glycylcycline Antibiotic, after Intravenous Infusion to Healthy Male Subjects Drug Metab. Dispos., September 1, 2007; 35(9): 1543 - 1553. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Chopra and M. Roberts Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance Microbiol. Mol. Biol. Rev., June 1, 2001; 65(2): 232 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Murakami, K. Tateda, T. Matsumoto, S. Miyazaki, and K. Yamaguchi Efficacy of a novel tetracycline derivative, glycylcycline, against penicillin-resistant Streptococcus pneumoniae in a mouse model of pneumonia J. Antimicrob. Chemother., October 1, 2000; 46(4): 629 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Hoellman, G. A. Pankuch, M. R. Jacobs, and P. C. Appelbaum Antipneumococcal Activities of GAR-936 (a New Glycylcycline) Compared to Those of Nine Other Agents against Penicillin-Susceptible and -Resistant Pneumococci Antimicrob. Agents Chemother., April 1, 2000; 44(4): 1085 - 1088. [Abstract] [Full Text] |
||||
![]() |
J. F. Barrett, R. M. Goldschmidt, L. E. Lawrence, B. Foleno, R. Chen, J. P. Demers, S. Johnson, R. Kanojia, J. Fernandez, J. Bernstein, et al. Antibacterial agents that inhibit two-component signal transduction systems PNAS, April 28, 1998; 95(9): 5317 - 5322. [Abstract] [Full Text] [PDF] |
||||




